Legal Representation
Attorney
Kevin Gannon
USPTO Deadlines
Application History
45 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 20, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Jun 20, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 20, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 20, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Nov 10, 2022 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
Sep 12, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Sep 12, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 12, 2022 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Aug 16, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Aug 1, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
May 10, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Mar 15, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 15, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 23, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 10, 2022 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Feb 9, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 9, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Feb 9, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 9, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 8, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 22, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Dec 22, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Dec 22, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 10, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 10, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Nov 10, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 9, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
Nov 4, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 2, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Nov 2, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Nov 2, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Nov 2, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 2, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 2, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Nov 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Nov 2, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Nov 2, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Oct 6, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Oct 6, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Oct 6, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 16, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 25, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
May 24, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Biomanufacturing for others, namely, manufacturing of tissue stem cells, engineered tissues, tissue stem cell bioreactors using biological organisms, namely, stem cells in the manufacturing process
Class 042
Life sciences biotechnology services in the nature of stem cell research services; Biotechnology research; Biotechnology testing in the nature of testing of pharmaceuticals; Research and development in the field of stem cells; Development and testing of computing methods, algorithms and software for medical, clinical, research and biomanufacturing purposes; Scientific and technological services, namely, research with diagnostic and therapeutic applications in the field of stem cells
First Use Anywhere:
Jan 1, 2015
First Use in Commerce:
Jan 1, 2015
Class 044
Stem Cell therapy services; Biotechnology testing in the nature of medical testing for diagnostic or treatment purposes
First Use Anywhere:
Jan 1, 2015
First Use in Commerce:
Jan 1, 2015
Classification
International Classes
040
042
044